Cargando…
Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
Due to the hypercoagulable status of patients with severe COVID-19 infection, anticoagulants are often used to prevent thrombosis. However, these agents may cause bleeding events such as retroperitoneal hematoma (RPH). We report here on six patients with COVID-19 who developed RPH during treatment....
Autores principales: | Hashemi, Huriyeh, Moradi, Hazhir, Hashemi, Marzieh, Naderi, Zohre, Jafarpisheh, Saleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465591/ https://www.ncbi.nlm.nih.gov/pubmed/36076361 http://dx.doi.org/10.1177/03000605221119662 |
Ejemplares similares
-
Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
por: Marzban-Rad, Saeid, et al.
Publicado: (2022) -
Femoral Nerve Palsy due to Anticoagulant Induced Retroperitoneal Hematoma
por: Gurbuz, Orcun, et al.
Publicado: (2014) -
Video-assisted retroperitoneal debridement for infected pancreatic necrosis: A single center series
por: Wu, Chih Ching, et al.
Publicado: (2022) -
Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021) -
Compressive femoral neuropathy caused by anticoagulant therapy induced retroperitoneal hematoma: A case report
por: Kim, Tae-Hoon, et al.
Publicado: (2022)